Prudential PLC Charles River Laboratories International, Inc. Transaction History

Prudential PLC

$19.6 Billion
Q3 2024

A detailed history of Prudential PLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Prudential PLC holds 1,978 shares of CRL stock, worth $387,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,978

Previous 1,978 -0.0%

Holding current value

$387,233

Previous $408,000 4.66%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$206.39 - $268.73 $408,239 - $531,547	1,978 New	1,978 $408,000
Q4 2023 Feb 13, 2024	SELL	$164.52 - $238.84 $1,316 - $1,910	-8 Reduced 0.34%	2,365 $559,000
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $2,755 - $3,153	-15 Reduced 0.63%	2,373 $498,000
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $1,535 - $2,079	8 Added 0.34%	2,388 $481,000
Q4 2022 Feb 08, 2023	BUY	$197.11 - $250.07 $243,825 - $309,336	1,237 Added 108.22%	2,380 $518,000
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $23,717 - $32,570	130 Added 12.83%	1,143 $225,000
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $31,844 - $47,174	-156 Reduced 13.34%	1,013 $217,000
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $298,691 - $423,306	1,169 New	1,169 $332,000
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $2.03 Million - $2.43 Million	-8,115 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$175.56 - $226.45 $148,699 - $191,803	-847 Reduced 9.45%	8,115 $1.84 Million
Q2 2020 Jul 31, 2020	BUY	$118.84 - $189.72 $1.07 Million - $1.7 Million	8,962 New	8,962 $1.56 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.

Account